{"id":59488,"date":"2023-01-25T12:41:51","date_gmt":"2023-01-25T02:11:51","guid":{"rendered":"https:\/\/www.aumanufacturing.com.au\/?p=59488"},"modified":"2023-01-25T15:03:04","modified_gmt":"2023-01-25T04:33:04","slug":"clinical-trial-on-schedule-and-600000-in-rd-funding-accessed-emvision","status":"publish","type":"post","link":"https:\/\/www.aumanufacturing.com.au\/clinical-trial-on-schedule-and-600000-in-rd-funding-accessed-emvision","title":{"rendered":"Clinical trial on schedule and $600,000 in R&D funding accessed: EMVision"},"content":{"rendered":"

Brain imaging technology company EMVision <\/span>Medical Devices has given an update on progress of its clinical trial and a Medical Research Future Fund-backed R&D program, with the latter seeing the company access a $600,000 milestone payment.<\/span><\/p>\n

The clinical trials <\/span><\/a>are in the pre-validation phase and running to schedule, according to a statement from EMVision on Wednesday.\u00a0<\/span><\/p>\n

EMVision is currently developing a first-generation scanner for bedside use in emergency departments and other clinical settings, in parallel with a <\/span>second-generation version designed for first responders<\/span><\/a>. These are an alternative to CT and MRI scans and designed for detection of strokes at a critical early stage.<\/a><\/span><\/p>

\"\"<\/a><\/div><\/div>\n

Approximately half of 30 participants for Stage 1 (healthy volunteers) have successfully enrolled in the clinical trial, with all 30 expected to be enrolled \u201cin the coming weeks\u201d, said EMVision. This will activate Stage 2 of the trial, \u201cinvolving up to 150 acute stroke\/stroke mimic patients.\u201d\u00a0<\/span><\/p>\n

The trial involves the first-generation bedside machine (pictured.)<\/span><\/p>\n

\u201cWe have strong clinical engagement and the ease of training and use of our device<\/a>, along with the speed of scanning, has certainly helped with the process,” said <\/span>CEO Dr Ron Weinberger.<\/span>\u00a0<\/span><\/p>

\"\"<\/a><\/div><\/div>\n

Weinberger\u2019s company also gave an update on <\/span>its five-year project, which was awarded $8 million in funding from the Australian government\u2019s Medical Research Future Fund (MRFF) program<\/a>, and is being carried out in partnership with the Australian Stroke Alliance (ASA.) This covers a more portable, second-generation scanner, with the company targeting trials in road and air ambulances next year.<\/span><\/p>\n

Funding is released in a stage-gated approach throughout the project, with the latest a $600,000 payment.<\/span><\/p>\n

\u201cThe testing conducted as part of our ASA milestones has shown encouraging benchtop results from our system enhancements which bodes well for our clinical trials,\u201d added Weinberger.\u00a0<\/span><\/p>\n

\u201cWe are excited with the progress being made with our 2<\/span>nd<\/span> Gen first responder model as well as our 1st Gen in-hospital device<\/a>.\u201d<\/span><\/p>\n

EMVision listed on the ASX in 2018<\/a>\u00a0and is a University of Queensland spinout, based on research by\u00a0Professor Amin Abbosh and Professor Stuart Crozier.<\/p>\n

Picture: Credit EMVision<\/p>\n","protected":false},"excerpt":{"rendered":"

Brain imaging technology company EMVision Medical Devices has given an update on progress of its clinical trial and a Medical Research Future Fund-backed R&D program, with the latter seeing the company access a $600,000 milestone payment. The clinical trials are in the pre-validation phase and running to schedule, according to a statement from EMVision on…<\/p>\n","protected":false},"author":25,"featured_media":59496,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[63],"tags":[],"acf":[],"yoast_head":"\nClinical trial on schedule and $600,000 in R&D funding accessed: EMVision - Australian Manufacturing Forum<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.aumanufacturing.com.au\/clinical-trial-on-schedule-and-600000-in-rd-funding-accessed-emvision\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Clinical trial on schedule and $600,000 in R&D funding accessed: EMVision - Australian Manufacturing Forum\" \/>\n<meta property=\"og:description\" content=\"Brain imaging technology company EMVision Medical Devices has given an update on progress of its clinical trial and a Medical Research Future Fund-backed R&D program, with the latter seeing the company access a $600,000 milestone payment. The clinical trials are in the pre-validation phase and running to schedule, according to a statement from EMVision on…\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.aumanufacturing.com.au\/clinical-trial-on-schedule-and-600000-in-rd-funding-accessed-emvision\" \/>\n<meta property=\"og:site_name\" content=\"Australian Manufacturing Forum\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-25T02:11:51+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-01-25T04:33:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.aumanufacturing.com.au\/wp-content\/uploads\/2023\/01\/1st-Gen-1-scaled-e1674621174507.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"600\" \/>\n\t<meta property=\"og:image:height\" content=\"325\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Staff Reporter\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@PeterTRoberts\" \/>\n<meta name=\"twitter:site\" content=\"@PeterTRoberts\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Staff Reporter\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.aumanufacturing.com.au\/clinical-trial-on-schedule-and-600000-in-rd-funding-accessed-emvision#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.aumanufacturing.com.au\/clinical-trial-on-schedule-and-600000-in-rd-funding-accessed-emvision\"},\"author\":{\"name\":\"Staff Reporter\",\"@id\":\"https:\/\/www.aumanufacturing.com.au\/#\/schema\/person\/24ac3b1df6c456019ce8e1cf8e0a8531\"},\"headline\":\"Clinical trial on schedule and $600,000 in R&D funding accessed: EMVision\",\"datePublished\":\"2023-01-25T02:11:51+00:00\",\"dateModified\":\"2023-01-25T04:33:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.aumanufacturing.com.au\/clinical-trial-on-schedule-and-600000-in-rd-funding-accessed-emvision\"},\"wordCount\":349,\"publisher\":{\"@id\":\"https:\/\/www.aumanufacturing.com.au\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.aumanufacturing.com.au\/clinical-trial-on-schedule-and-600000-in-rd-funding-accessed-emvision#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.aumanufacturing.com.au\/wp-content\/uploads\/2023\/01\/1st-Gen-1-scaled-e1674621174507.jpg\",\"articleSection\":[\"Manufacturing News\"],\"inLanguage\":\"en-AU\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.aumanufacturing.com.au\/clinical-trial-on-schedule-and-600000-in-rd-funding-accessed-emvision\",\"url\":\"https:\/\/www.aumanufacturing.com.au\/clinical-trial-on-schedule-and-600000-in-rd-funding-accessed-emvision\",\"name\":\"Clinical trial on schedule and $600,000 in R&D funding accessed: EMVision - Australian Manufacturing Forum\",\"isPartOf\":{\"@id\":\"https:\/\/www.aumanufacturing.com.au\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.aumanufacturing.com.au\/clinical-trial-on-schedule-and-600000-in-rd-funding-accessed-emvision#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.aumanufacturing.com.au\/clinical-trial-on-schedule-and-600000-in-rd-funding-accessed-emvision#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.aumanufacturing.com.au\/wp-content\/uploads\/2023\/01\/1st-Gen-1-scaled-e1674621174507.jpg\",\"datePublished\":\"2023-01-25T02:11:51+00:00\",\"dateModified\":\"2023-01-25T04:33:04+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.aumanufacturing.com.au\/clinical-trial-on-schedule-and-600000-in-rd-funding-accessed-emvision#breadcrumb\"},\"inLanguage\":\"en-AU\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.aumanufacturing.com.au\/clinical-trial-on-schedule-and-600000-in-rd-funding-accessed-emvision\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-AU\",\"@id\":\"https:\/\/www.aumanufacturing.com.au\/clinical-trial-on-schedule-and-600000-in-rd-funding-accessed-emvision#primaryimage\",\"url\":\"https:\/\/www.aumanufacturing.com.au\/wp-content\/uploads\/2023\/01\/1st-Gen-1-scaled-e1674621174507.jpg\",\"contentUrl\":\"https:\/\/www.aumanufacturing.com.au\/wp-content\/uploads\/2023\/01\/1st-Gen-1-scaled-e1674621174507.jpg\",\"width\":600,\"height\":325},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.aumanufacturing.com.au\/clinical-trial-on-schedule-and-600000-in-rd-funding-accessed-emvision#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.aumanufacturing.com.au\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Clinical trial on schedule and $600,000 in R&D funding accessed: EMVision\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.aumanufacturing.com.au\/#website\",\"url\":\"https:\/\/www.aumanufacturing.com.au\/\",\"name\":\"Australian Manufacturing Forum\",\"description\":\"Powered by the Australian Manufacturing Forum\",\"publisher\":{\"@id\":\"https:\/\/www.aumanufacturing.com.au\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.aumanufacturing.com.au\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-AU\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.aumanufacturing.com.au\/#organization\",\"name\":\"Australian Manufacturing Forum\",\"url\":\"https:\/\/www.aumanufacturing.com.au\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-AU\",\"@id\":\"https:\/\/www.aumanufacturing.com.au\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.aumanufacturing.com.au\/wp-content\/uploads\/2020\/07\/@auman-logo.png\",\"contentUrl\":\"https:\/\/www.aumanufacturing.com.au\/wp-content\/uploads\/2020\/07\/@auman-logo.png\",\"width\":73,\"height\":73,\"caption\":\"Australian Manufacturing Forum\"},\"image\":{\"@id\":\"https:\/\/www.aumanufacturing.com.au\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/PeterTRoberts\",\"https:\/\/www.linkedin.com\/company\/aumanufacturing\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.aumanufacturing.com.au\/#\/schema\/person\/24ac3b1df6c456019ce8e1cf8e0a8531\",\"name\":\"Staff Reporter\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-AU\",\"@id\":\"https:\/\/www.aumanufacturing.com.au\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/97608aaf0f585c19b8b3aca588d0e58c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/97608aaf0f585c19b8b3aca588d0e58c?s=96&d=mm&r=g\",\"caption\":\"Staff Reporter\"},\"sameAs\":[\"http:\/\/aumanufacturing.com.au\"],\"url\":\"https:\/\/www.aumanufacturing.com.au\/author\/editor\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Clinical trial on schedule and $600,000 in R&D funding accessed: EMVision - Australian Manufacturing Forum","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.aumanufacturing.com.au\/clinical-trial-on-schedule-and-600000-in-rd-funding-accessed-emvision","og_locale":"en_US","og_type":"article","og_title":"Clinical trial on schedule and $600,000 in R&D funding accessed: EMVision - Australian Manufacturing Forum","og_description":"Brain imaging technology company EMVision Medical Devices has given an update on progress of its clinical trial and a Medical Research Future Fund-backed R&D program, with the latter seeing the company access a $600,000 milestone payment. The clinical trials are in the pre-validation phase and running to schedule, according to a statement from EMVision on…","og_url":"https:\/\/www.aumanufacturing.com.au\/clinical-trial-on-schedule-and-600000-in-rd-funding-accessed-emvision","og_site_name":"Australian Manufacturing Forum","article_published_time":"2023-01-25T02:11:51+00:00","article_modified_time":"2023-01-25T04:33:04+00:00","og_image":[{"width":600,"height":325,"url":"https:\/\/www.aumanufacturing.com.au\/wp-content\/uploads\/2023\/01\/1st-Gen-1-scaled-e1674621174507.jpg","type":"image\/jpeg"}],"author":"Staff Reporter","twitter_card":"summary_large_image","twitter_creator":"@PeterTRoberts","twitter_site":"@PeterTRoberts","twitter_misc":{"Written by":"Staff Reporter","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.aumanufacturing.com.au\/clinical-trial-on-schedule-and-600000-in-rd-funding-accessed-emvision#article","isPartOf":{"@id":"https:\/\/www.aumanufacturing.com.au\/clinical-trial-on-schedule-and-600000-in-rd-funding-accessed-emvision"},"author":{"name":"Staff Reporter","@id":"https:\/\/www.aumanufacturing.com.au\/#\/schema\/person\/24ac3b1df6c456019ce8e1cf8e0a8531"},"headline":"Clinical trial on schedule and $600,000 in R&D funding accessed: EMVision","datePublished":"2023-01-25T02:11:51+00:00","dateModified":"2023-01-25T04:33:04+00:00","mainEntityOfPage":{"@id":"https:\/\/www.aumanufacturing.com.au\/clinical-trial-on-schedule-and-600000-in-rd-funding-accessed-emvision"},"wordCount":349,"publisher":{"@id":"https:\/\/www.aumanufacturing.com.au\/#organization"},"image":{"@id":"https:\/\/www.aumanufacturing.com.au\/clinical-trial-on-schedule-and-600000-in-rd-funding-accessed-emvision#primaryimage"},"thumbnailUrl":"https:\/\/www.aumanufacturing.com.au\/wp-content\/uploads\/2023\/01\/1st-Gen-1-scaled-e1674621174507.jpg","articleSection":["Manufacturing News"],"inLanguage":"en-AU"},{"@type":"WebPage","@id":"https:\/\/www.aumanufacturing.com.au\/clinical-trial-on-schedule-and-600000-in-rd-funding-accessed-emvision","url":"https:\/\/www.aumanufacturing.com.au\/clinical-trial-on-schedule-and-600000-in-rd-funding-accessed-emvision","name":"Clinical trial on schedule and $600,000 in R&D funding accessed: EMVision - Australian Manufacturing Forum","isPartOf":{"@id":"https:\/\/www.aumanufacturing.com.au\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.aumanufacturing.com.au\/clinical-trial-on-schedule-and-600000-in-rd-funding-accessed-emvision#primaryimage"},"image":{"@id":"https:\/\/www.aumanufacturing.com.au\/clinical-trial-on-schedule-and-600000-in-rd-funding-accessed-emvision#primaryimage"},"thumbnailUrl":"https:\/\/www.aumanufacturing.com.au\/wp-content\/uploads\/2023\/01\/1st-Gen-1-scaled-e1674621174507.jpg","datePublished":"2023-01-25T02:11:51+00:00","dateModified":"2023-01-25T04:33:04+00:00","breadcrumb":{"@id":"https:\/\/www.aumanufacturing.com.au\/clinical-trial-on-schedule-and-600000-in-rd-funding-accessed-emvision#breadcrumb"},"inLanguage":"en-AU","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.aumanufacturing.com.au\/clinical-trial-on-schedule-and-600000-in-rd-funding-accessed-emvision"]}]},{"@type":"ImageObject","inLanguage":"en-AU","@id":"https:\/\/www.aumanufacturing.com.au\/clinical-trial-on-schedule-and-600000-in-rd-funding-accessed-emvision#primaryimage","url":"https:\/\/www.aumanufacturing.com.au\/wp-content\/uploads\/2023\/01\/1st-Gen-1-scaled-e1674621174507.jpg","contentUrl":"https:\/\/www.aumanufacturing.com.au\/wp-content\/uploads\/2023\/01\/1st-Gen-1-scaled-e1674621174507.jpg","width":600,"height":325},{"@type":"BreadcrumbList","@id":"https:\/\/www.aumanufacturing.com.au\/clinical-trial-on-schedule-and-600000-in-rd-funding-accessed-emvision#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.aumanufacturing.com.au\/"},{"@type":"ListItem","position":2,"name":"Clinical trial on schedule and $600,000 in R&D funding accessed: EMVision"}]},{"@type":"WebSite","@id":"https:\/\/www.aumanufacturing.com.au\/#website","url":"https:\/\/www.aumanufacturing.com.au\/","name":"Australian Manufacturing Forum","description":"Powered by the Australian Manufacturing Forum","publisher":{"@id":"https:\/\/www.aumanufacturing.com.au\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.aumanufacturing.com.au\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-AU"},{"@type":"Organization","@id":"https:\/\/www.aumanufacturing.com.au\/#organization","name":"Australian Manufacturing Forum","url":"https:\/\/www.aumanufacturing.com.au\/","logo":{"@type":"ImageObject","inLanguage":"en-AU","@id":"https:\/\/www.aumanufacturing.com.au\/#\/schema\/logo\/image\/","url":"https:\/\/www.aumanufacturing.com.au\/wp-content\/uploads\/2020\/07\/@auman-logo.png","contentUrl":"https:\/\/www.aumanufacturing.com.au\/wp-content\/uploads\/2020\/07\/@auman-logo.png","width":73,"height":73,"caption":"Australian Manufacturing Forum"},"image":{"@id":"https:\/\/www.aumanufacturing.com.au\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/PeterTRoberts","https:\/\/www.linkedin.com\/company\/aumanufacturing\/"]},{"@type":"Person","@id":"https:\/\/www.aumanufacturing.com.au\/#\/schema\/person\/24ac3b1df6c456019ce8e1cf8e0a8531","name":"Staff Reporter","image":{"@type":"ImageObject","inLanguage":"en-AU","@id":"https:\/\/www.aumanufacturing.com.au\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/97608aaf0f585c19b8b3aca588d0e58c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/97608aaf0f585c19b8b3aca588d0e58c?s=96&d=mm&r=g","caption":"Staff Reporter"},"sameAs":["http:\/\/aumanufacturing.com.au"],"url":"https:\/\/www.aumanufacturing.com.au\/author\/editor"}]}},"_links":{"self":[{"href":"https:\/\/www.aumanufacturing.com.au\/wp-json\/wp\/v2\/posts\/59488"}],"collection":[{"href":"https:\/\/www.aumanufacturing.com.au\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.aumanufacturing.com.au\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.aumanufacturing.com.au\/wp-json\/wp\/v2\/users\/25"}],"replies":[{"embeddable":true,"href":"https:\/\/www.aumanufacturing.com.au\/wp-json\/wp\/v2\/comments?post=59488"}],"version-history":[{"count":0,"href":"https:\/\/www.aumanufacturing.com.au\/wp-json\/wp\/v2\/posts\/59488\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.aumanufacturing.com.au\/wp-json\/wp\/v2\/media\/59496"}],"wp:attachment":[{"href":"https:\/\/www.aumanufacturing.com.au\/wp-json\/wp\/v2\/media?parent=59488"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.aumanufacturing.com.au\/wp-json\/wp\/v2\/categories?post=59488"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.aumanufacturing.com.au\/wp-json\/wp\/v2\/tags?post=59488"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}